Submitted by kBLASTER Team on
by PRNewswire
LITTLETON, Colo. and SEATTLE, Jan. 6, 2015 /PRNewswire/ -- dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its novel bladder scanner, the BBS Revolution™, a device offering unparalleled ease of use, speed and accuracy for the non-invasive measurement of bladder volume.
Bladder scanning is a critical component of a comprehensive catheter-associated urinary tract infection (CAUTI) prevention program, an area of intense focus for hospitals given recent Medicare penalties for hospitals with high CAUTI rates as part of the Medicare hospital-acquired condition (HAC) reduction program. Under this program, the Centers for Medicare & Medicaid Services (CMS) are reducing payments by one percent for hospitals with a high number of HACs (including CAUTIs). The BBS Revolution™ is used to measure bladder volume and provide rapid, objective information on the necessity for a urinary catheter, the primary source of CAUTIs in hospitals.
Go to kBLASTER to FDA 510(k) search for a primary predicate, multiple predicates or reference devices, and harness kBLASTER's uniquely effective result management features, so you can quickly build a successful 510(k) clearance strategy.